Ferodo America Inc. Asbestos Trust Claims
Ferodo America Inc. asbestos claims are handled through the T&N Subfund of the Federal-Mogul Asbestos Personal Injury Trust. Ferodo is one of the T&N Entities expressly identified in the governing Federal-Mogul Trust Distribution Procedures and Trust Agreement. Ferodo does not have a separately funded stand-alone asbestos trust under this structure. Its qualifying claims share the T&N Subfund claim process, while Ferodo has its own published disease values within the TDP.
Ferodo America Asbestos Trust Facts
| Formal trust | Federal-Mogul Asbestos Personal Injury Trust |
|---|---|
| Applicable account | T&N Subfund |
| Covered entity | Ferodo America Inc. |
| Related T&N entities | Turner & Newall and Gasket Holdings Inc. / Flexitallic |
| Federal-Mogul Chapter 11 petition date | October 1, 2001 |
| Plan effective / Trust established | December 27, 2007 |
| T&N Subfund began receiving claims | August 25, 2010 |
| Current T&N Subfund Payment Percentage | 2.9% |
| Current rate effective date | June 30, 2026 |
| Ferodo Mesothelioma Scheduled Value | $50,000 |
| Ferodo Mesothelioma Average Value | $62,500 |
| Ferodo Mesothelioma Maximum Value | $150,000 |
| Current status | Active |
Why Ferodo Claims Use the T&N Subfund
The Federal-Mogul Trust Agreement identifies Turner & Newall and its direct or indirect U.S. subsidiaries, including Ferodo America Inc., as T&N Entities. The Agreement created four separate subfunds: T&N, FMP, Fel-Pro and Vellumoid.
The T&N Subfund processes claims for T&N, Flexitallic and Ferodo liabilities. Therefore, a page about a “Ferodo asbestos trust” should identify the formal structure correctly rather than suggesting that Ferodo received a separate fifth subfund.
The official proof-of-claim form requires a claimant filing against the T&N Subfund to identify whether the specific exposure alleged is T&N, Flexitallic or Ferodo exposure.
Federal-Mogul Bankruptcy and Trust History
Federal-Mogul and various subsidiaries filed Chapter 11 cases on October 1, 2001. The Bankruptcy Court confirmed the Fourth Amended Joint Plan of Reorganization in November 2007, and the Plan became effective on December 27, 2007.
The Federal-Mogul Asbestos Personal Injury Trust was established on the Effective Date to resolve qualifying asbestos personal-injury claims associated with the Federal-Mogul entities identified in the Plan and Trust Agreement, including Ferodo.
The T&N Subfund began receiving and processing T&N, Flexitallic and Ferodo claims on August 25, 2010. The Trust remains active.
Ferodo Disease Values
The Federal-Mogul TDP publishes a combined Flexitallic/Ferodo disease-value schedule. These values must not be confused with the higher T&N values or with the separate FMP schedule:
| Disease Level | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| VIII — Mesothelioma | $50,000 | $62,500 | $150,000 |
| VII — Lung Cancer 1 | $10,625 | $15,000 | $31,250 |
| VI — Lung Cancer 2 | Individual Review only | $3,000 | $10,000 |
| V — Other Cancer | $3,700 | $4,900 | $22,500 |
| IV — Severe Asbestosis | $10,625 | $13,625 | $31,250 |
| III — Asbestosis/Pleural Disease | $3,175 | $3,375 | $6,250 |
| II — Asbestosis/Pleural Disease | $1,425 | $1,450 | $2,000 |
| I — Other Asbestos Disease | $50 Cash Discount Payment | None | None |
These are the governing TDP values published for Flexitallic/Ferodo claims. They are not guaranteed payments. The applicable Payment Percentage and other TDP provisions determine the amount actually payable on an allowed claim.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Current 2.9% Payment Percentage
The latest T&N Sub-Account payment-percentage notice supports a 2.9% Payment Percentage effective June 30, 2026. This percentage applies to the T&N Subfund, which processes Ferodo claims. It must not be replaced with a payment percentage belonging to the separate FMP, Fel-Pro or Vellumoid accounts.
Mathematical illustration only — not a guaranteed payment. A Ferodo Mesothelioma claim allowed at the $50,000 Scheduled Value × 2.9% = approximately $1,450. A claim valued at the $62,500 Average Value × 2.9% = approximately $1,812.50. A $150,000 Maximum Value × 2.9% = approximately $4,350.
Average and Maximum Values are not automatic awards. Individual Review, claim-specific facts, sequencing adjustments and other provisions of the TDP can affect valuation and payment.
Medical and Ferodo Exposure Requirements
To qualify for payment, a claimant must submit credible medical and exposure evidence and a claim that the Trust considers complete. The TDP establishes separate medical and exposure criteria for each disease level.
Mesothelioma Level VIII requires a qualifying mesothelioma diagnosis and credible evidence of exposure to a covered T&N Entity product or operation. Other disease levels can require additional occupational-exposure, medical-causation and nonmalignant-disease evidence.
Ferodo claimants should identify exposure specifically attributable to Ferodo rather than relying solely on exposure to another Federal-Mogul entity. The official claim form separately identifies Ferodo exposure for this reason.
Ferodo Claim Filing and Review
A direct Ferodo claim is filed with the T&N Subfund of the Federal-Mogul Asbestos Personal Injury Trust. The official claim materials provide two principal review choices: Expedited Review and Individual Review.
Expedited Review is not available for Lung Cancer 2 Level VI claims, Secondary Exposure Claims or Foreign Claims. Level VI Lung Cancer 2 claims must be individually reviewed; the TDP states an anticipated average award of $3,000 and a $10,000 ordinary cap for valid Flexitallic/Ferodo Level VI claims, before application of the applicable Payment Percentage.
The Trust also has procedures for Indirect Claims based on contribution, indemnification or reimbursement. The official Ferodo Indirect Claim instructions require compliance with TDP section 5.6.
Separate T&N, Flexitallic and Ferodo Claims
The official Federal-Mogul proof-of-claim form states that a claimant must check only one T&N Subfund entity for the specific exposure alleged: T&N, Flexitallic or Ferodo.
When a claimant alleges exposure to more than one T&N Subfund entity, the Trust instructs that the claims be filed separately. For example, a claimant alleging both T&N and Ferodo exposure must submit a complete T&N exposure claim and a separate complete Ferodo exposure claim.
This separation is important because T&N and Flexitallic/Ferodo use different disease-value schedules. The $200,000 T&N Mesothelioma Scheduled Value should not be substituted for the $50,000 Ferodo Scheduled Value.
The latest current payment rate is account-specific as well. This page uses the T&N Subfund’s 2.9% rate and does not conflate it with the payment percentage of the separate FMP Subfund.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for the trust facts in this page. Primary materials reviewed include:
- Official Federal-Mogul Asbestos Personal Injury Trust Distribution Procedures.
- Official T&N Subfund filing instructions covering T&N, Flexitallic and Ferodo claims.
- Official Federal-Mogul proof-of-claim form requiring separate identification of Ferodo exposure.
- Official Ferodo Indirect Claim filing instructions.
- SEC-filed Federal-Mogul Asbestos Personal Injury Trust Agreement identifying Ferodo America Inc. as a T&N Entity and establishing the four subfunds.
- Federal-Mogul Trust T&N Sub-Account payment-percentage notice supporting the 2.9% rate effective June 30, 2026.
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Ferodo Filing and Eligibility
Payments and Legal Procedures
- Official current T&N payment-percentage notice
- Official Federal-Mogul Trust Distribution Procedures
- Official Ferodo Indirect Claim instructions
Frequently Asked Questions About the Ferodo America Asbestos Trust
Does Ferodo America have its own separate asbestos trust?
No. Qualifying Ferodo America claims are handled by the T&N Subfund of the Federal-Mogul Asbestos Personal Injury Trust.
What is the current Ferodo Payment Percentage?
The current T&N Subfund Payment Percentage is 2.9%, effective June 30, 2026. Ferodo claims are processed by that subfund.
What is the Ferodo Mesothelioma Scheduled Value?
The Federal-Mogul TDP lists a $50,000 Scheduled Value, $62,500 Average Value and $150,000 Maximum Value for Flexitallic/Ferodo Mesothelioma Level VIII claims.
What does 2.9% of the Ferodo Mesothelioma Scheduled Value equal?
$50,000 multiplied by 2.9% equals approximately $1,450. This is a mathematical illustration only — not a guaranteed payment.
What is the Ferodo Lung Cancer 1 Scheduled Value?
The Flexitallic/Ferodo Lung Cancer 1 Level VII Scheduled Value is $10,625, with a $15,000 Average Value and $31,250 Maximum Value.
Can a claimant file both T&N and Ferodo exposure claims?
Yes, but the official instructions require multiple T&N Subfund exposure claims to be filed separately. A T&N exposure claim and Ferodo exposure claim require separate complete claim forms.
Does Ferodo Lung Cancer 2 have a Scheduled Value?
No. Level VI Lung Cancer 2 is an Individual Review claim. The TDP lists a $3,000 anticipated average and $10,000 ordinary maximum for valid Flexitallic/Ferodo claims before the applicable Payment Percentage.
Who administers Ferodo asbestos claims?
Ferodo claims are processed through the T&N Subfund of the Federal-Mogul Asbestos Personal Injury Trust under the Trust’s current claim administration procedures.
Get Help Reviewing a Ferodo America Asbestos Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Working with or around Ferodo friction products does not automatically establish asbestos exposure, Trust eligibility or compensation. Eligibility depends on diagnosis, qualifying Ferodo exposure evidence, the applicable TDP criteria, filing requirements and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.